Award
NIH Reporter #1R35GM160352-01
Myeloid-Derived Suppressor Cells in Immunological Endotyping and Intervention of Chronic Critical Illness after Sepsis
Recipient
Not specified
Award Amount
$422,125.00
Ceiling
$422,125.00
Awarded
August 22, 2025
Identifier
1R35GM160352-01
Award for research on myeloid-derived suppressor cells to improve diagnosis and treatment of chronic critical illness after sepsis, funded by NIH/NIGMS.
Description
The project focuses on validating genomic features of myeloid-derived suppressor cells (MDSCs) as biomarkers for early diagnosis of immunosuppression in sepsis patients. The research aims to delineate interactions between MDSCs and T cells, and identify potential drugs for clinical development. The project involves multi-omics and AI/statistical approaches.